Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -44.87%27.38M | 40.48%49.66M | 2.38%35.35M | 11.40%34.53M | 17.64%30.99M | -9.05%26.34M | 134.85%28.96M | -50.90%12.33M | 37.48%25.12M | 18.27M |
| Cost of revenue | -42.08%14.65M | 45.98%25.29M | 14.02%17.32M | 27.21%15.19M | -9.54%11.94M | -11.91%13.2M | 88.26%14.99M | -45.90%7.96M | 40.14%14.72M | 10.5M |
| Gross profit | -47.76%12.73M | 35.20%24.37M | -6.77%18.03M | 1.48%19.33M | 44.96%19.05M | -5.97%13.14M | 219.68%13.98M | -57.98%4.37M | 33.87%10.4M | 7.77M |
| Operating expense | -54.75%11.9M | 56.71%26.3M | 0.36%16.78M | -19.06%16.72M | 89.55%20.66M | 4.32%10.9M | 778.09%10.45M | -78.11%1.19M | 92.84%5.44M | 2.82M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Selling and administrative expenses | -47.46%14.33M | 62.10%27.27M | 0.15%16.82M | -18.78%16.8M | 88.41%20.68M | 0.51%10.98M | 239.51%10.92M | 60.77%3.22M | 16.81%2M | --1.71M |
| -General and administrative expense | -47.46%14.33M | 62.10%27.27M | 0.15%16.82M | -18.78%16.8M | 88.41%20.68M | 0.51%10.98M | 239.51%10.92M | 60.77%3.22M | 16.81%2M | --1.71M |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 26.64%1.27M | --1.01M |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 26.64%1.27M | --1.01M |
| Rent and land expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 39.59%2.86M | --2.05M |
| Total other operating income | 150.41%2.43M | 2,325.00%970K | -46.67%40K | 256.97%75K | -72.70%21.01K | -83.75%76.96K | -76.64%473.54K | 188.77%2.03M | -64.02%701.97K | --1.95M |
| Operating profit | 142.91%829K | -255.68%-1.93M | -52.45%1.24M | 262.05%2.61M | -171.84%-1.61M | -36.46%2.24M | 10.88%3.53M | -35.95%3.18M | 0.30%4.97M | 4.95M |
| Net non-operating interest income (expenses) | 65.50%-641K | -78.65%-1.86M | -1.86%-1.04M | -241.79%-1.02M | 43.98%-298.72K | -11.73%-533.22K | -113.17%-477.25K | 26.22%-223.89K | -1.72%-303.44K | -298.3K |
| Non-operating interest income | ---- | ---- | ---- | -99.12%924 | 142.72%104.91K | -85.22%43.22K | --292.37K | ---- | ---- | ---- |
| Non-operating interest expense | -65.50%641K | 78.65%1.86M | 1.86%1.04M | 152.95%1.02M | -29.98%403.63K | -25.10%576.44K | 243.76%769.62K | -26.22%223.89K | 1.72%303.44K | --298.3K |
| Net investment income | 16.18K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -45.79%56.26K | -7.87%103.78K | -77.53%112.64K | 501.35K | ||||||
| Less:Other special charges | ---- | ---- | ---- | 45.79%-56.26K | 7.87%-103.78K | 77.53%-112.64K | ---501.35K | ---- | ---- | ---- |
| Other non-operating income (expenses) | 18.09K | |||||||||
| Income before tax | 104.96%188K | -1,985.57%-3.79M | -87.35%201K | 188.80%1.59M | -198.24%-1.79M | -48.73%1.82M | 20.09%3.55M | -36.59%2.96M | 0.21%4.67M | 4.66M |
| Income tax | -17.55%202K | 282.81%245K | -88.41%64K | 1,245.69%552K | -95.56%41.02K | -16.77%923.17K | 40.24%1.11M | -17.65%790.87K | -21.24%960.43K | 1.22M |
| Net income | 99.63%-15K | -3,023.91%-4.04M | -86.69%138K | 156.65%1.04M | -303.76%-1.83M | -63.24%898.31K | 12.74%2.44M | -41.50%2.17M | 7.82%3.71M | 3.44M |
| Net income continuous operations | 99.65%-14K | -3,045.26%-4.04M | -86.79%137K | 156.65%1.04M | -303.76%-1.83M | -63.24%898.31K | 12.74%2.44M | -41.50%2.17M | 7.82%3.71M | --3.44M |
| Noncontrolling interests | 36.84%104K | 61.70%76K | 30.56%47K | 1,801.74%36K | 102.03%1.89K | -78.57%-93.13K | -52.16K | |||
| Net income attributable to the company | 97.13%-118K | -4,617.58%-4.11M | -90.91%91K | 154.63%1M | -284.81%-1.83M | -60.28%991.44K | 15.14%2.5M | -41.50%2.17M | 7.82%3.71M | 3.44M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 97.13%-118K | -4,617.58%-4.11M | -90.91%91K | 154.63%1M | -284.81%-1.83M | -60.28%991.44K | 15.14%2.5M | -41.50%2.17M | 7.82%3.71M | 3.44M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 97.12%-0.0005 | -4,627.78%-0.0163 | -91.00%0.0004 | 156.34%0.004 | -277.50%-0.0071 | -62.96%0.004 | -88.17%0.0108 | 534.04%0.0913 | -7.69%0.0144 | 0.0156 |
| Diluted earnings per share | 97.12%-0.0005 | -6,369.23%-0.0163 | -90.88%0.0003 | 140.14%0.0029 | -277.50%-0.0071 | -62.96%0.004 | -88.17%0.0108 | 534.04%0.0913 | -7.69%0.0144 | 0.0156 |
| Dividend per share | 0 | 0.00%0.0005 | -75.00%0.0005 | -33.33%0.002 | -37.50%0.003 | 0.0048 | ||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.